Lubberman F, Gelderblom H, Hamberg P, et al. A reduced pazopanib dose with food: Is it more patient-friendly and does it reduce drug costs? ASCO Annual Meeting 2019, abstract 4564.
Alectinib versus crizotinib bij ALK-positief NSCLC
jun 2017 | Longoncologie